Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse

Immunity

Volumn 18, Issue 3, 2003, Pages 367-379

  Sato, Katsuaki ^a   Yamashita, Naohide ^b   Yamashita, Naomi ^c   Baba, Masanori ^a   Matsuyama, Takami ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; DENDRITIC CELL; GRAFT VERSUS HOST REACTION; IMMUNOREGULATION; LEUKEMIA REMISSION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0037339812     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00055-4     Document Type: Article

References (24)

1. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.-J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:2000;767-811.
2. kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat. Med. 6:2000;290-297.
3. 3 and its analogs. a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo Proc. Natl. Acad. Sci. USA. 98:2001;6800-6805.
4. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.M., Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:2001;769-779.
5. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196:2002;389-399.
6. +T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:2000;1213-1222.
7. Lu Y., Sakamaki S., Kuroda H., Kusakabe T., Konuma Y., Akiyama T., Fujimi A., Takemoto N., Nishiie K., Matsunaga T.et al. Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603. Blood. 97:2001;1123-1130.
8. Maloy K.J., Powrie F. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:2001;816-822.
9. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164:2000;2405-2411.
10. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196:2002;237-246.
11. Roncarolo M.-C., Levings M.K., Traverari C. Differentiation of T regulatory cells by immature dendritic cells. J. Exp. Med. 193:2001;F5-F9.
12. Sakaguchi S. Regulatory T cells. key controllers of immunologic self-tolerance Cell. 101:2000;455-458.
13. Sato K., Nagayama H., Takahashi T.A. Aberrant CD3- and CD28-mediated signaling events in cord blood T cells are associated with dysfunctional regulation of Fas ligand-mediated cytotoxicity. J. Immunol. 162:1999;4464-4471.
14. +T cells via presentation of the internalized soluble antigen and cross-presentation of the phagocytosed necrotic cellular fragments. Cell. Immunol. 215:2002;186-194.
15. Sato K., Yamashita N., Baba M., Matsuyama T. Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood. 101:2003;. in press.
16. + suppressor T cells J. Exp. Med. 193:2001;F41-F45.
17. Shlomchik W.D., Couzens M.S., Tang C.B., McNiff J., Robert M.E., Liu J., Shlomchik M.J., Emerson S.G. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science. 285:1999;412-415.
18. Steinbrink K., Wolfl M., Jonuleit H., Knop J., Enk A.H. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:1997;4772-4780.
19. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:2000;303-309.
20. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 99:2002;3493-3499.
21. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:1998;287-296.
22. Tsukada N., Tsukada N., Kobata T., Aizawa Y., Yagita H., Okumura K. Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation. Blood. 93:1999;2738-2747.
23. Viola A., Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science. 273:1996;104-106.
24. + regulatory cells? Immunity. 14:2001;399-406.